Skip to main content

VGM & ASSOCIATESHealthcare MSO

Search GO

Search GO

VGM & ASSOCIATESHealthcare MSO LEARN ABOUT VGM

Government Relations Advocate for the Breast Cancer Patient Equity Act

Published in Government Relations on June 20, 2024

The week of June 3rd, Nikki Jensen, VP of Essentially Women and Ike Isaacson, SVP of VGM Government & Regulatory Relations traveled to Washington D.C. to advocate for H.R. 4779/S. 3069, the Breast Cancer Patient Equity Act. This bill would allow Medicare to recognize custom breast prosthesis as an eligible breast replacement following mastectomy surgery. Currently, Medicare beneficiaries are allowed the option of an off-the-shelf prosthetic or surgical reconstruction. Since December 2020, this bill has had an inflated Congressional Budget Office (CBO) score; misrepresenting the cost of this bill. Nikki and Ike met with the offices of Senate lead sponsors, Sen. Tammy Duckworth (D-IL) and Sen. Lisa Murkowski (R-AK) as well as House leads, Rep. Mariannette Miller-Meeks (R-IA) and Rep. Judy Chu (D-CA) to request letters be sent to the CBO to re-score the bill.

This bill is significant because some women are not candidates based on medical recommendations or for personal reasons, do not choose to undergo additional surgical procedures after their mastectomy surgery. Limitations to off-the-shelf prosthetics include proper fit against the chest wall after surgery and/or radiation, finding symmetry to their remaining breast or matching skin tone.

One in eight women will be diagnosed with breast cancer in their lifetime. Women don’t know what option they may need until faced with the decision. The objective of the Breast Cancer Patient Equity Act is to ensure women have the appropriate choice to make the decision that’s best for them at that time. Approximately 70% of state Medicaid programs, Tricare, and many private insurance payers allow coverage for custom breast prosthesis.

We encourage you to contact your legislators to advocate for this bill.

From Our Experts

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail

HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry.

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk.

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review.

Evaluating the Value of a Payer Contract thumbnail

Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort.

Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.

The Return of Competitive Bidding thumbnail

The Return of Competitive Bidding The Centers for Medicare & Medicaid Services (CMS) appear to be laying the groundwork for another round of the Competitive Bidding Program (CBP). While full implementation will take a couple of years, an official announcement is expected this summer—potentially as early as July.

Out With The Old RAC, In With The New thumbnail

Out With The Old RAC, In With The New On April 28, 2025, CMS awarded Cotiviti GOV Services LLC, the new RAC Recovery Audit Contractor (RAC) Region 3, 4, and 5 contracts. RAC Region 3 includes the following Medicare Administrative Contractor (MAC) jurisdictions: JJ, JM, and JN. RAC Region 4 includes jurisdictions: JE, JF, and JL. And RAC Region 5 includes jurisdictions: JA, JB, JC, JD, as well as the HH/H MACs: J6, J15, JK, and JM.

Be Part of Something Bigger

Become a Member